← United States · Coverage record
US · SEC FORM 4
ORASURE TECHNOLOGIES INC
OSUR · Nasdaq · CIK 0001116463 · Healthcare · Medical Instruments & Supplies
INSIDER SIGNAL
1 buyers · 3 purchase transaction lines · $224.8K gross purchase
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
What is holding the score back?
- ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Purchase activity is becoming less recent
- ✓ Role scores high · most senior buyer: Director
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
—
Purchase breadth & concentration
Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.
SIGNAL HISTORY
Latest recorded score
- 48.7
- 48.7
- 48.6
- 48.6
- 48.5
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.
Price performance
- 1M
- +20.7%
- 3M
- -9.3%
- 6M
- +31.8%
- 12M
- +20.4%
Volatility & liquidity
- Volatility
- 50.7%
- Beta
- —
- Avg daily value
- USD 1.9M
Valuation
- Market cap
- USD 269.0M
- P/E
- —
Fundamentals
- Profit margin
- -59.8%
- ROE
- -20.2%
- Industry
- Medical Instruments & Supplies
Market data
Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · Status: PASS
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 2,930,877
- Previous report
- 3,172,198
- Avg daily volume
- 649,029
- Days to cover
- 4.5
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 2.99 | USD 74,750 | SEC filing ↗ |
| 2026-05-13 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 3.02 | USD 75,500 | SEC filing ↗ |
| 2026-05-12 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 2.98 | USD 74,500 | SEC filing ↗ |
| 2026-03-20 | McGrath Kenneth J | Purchase (P) | Common Stock | 32,300 | USD 2.93 | USD 94,639 | SEC filing ↗ |
| 2026-03-20 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 32,300 | USD 2.93 | USD 94,639 | SEC filing ↗ |
| 2026-03-13 | McGrath Kenneth J | Purchase (P) | Common Stock | 22,021 | USD 3.00 | USD 66,063 | SEC filing ↗ |
| 2026-03-13 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 22,022 | USD 3.00 | USD 66,066 | SEC filing ↗ |
| 2025-11-28 | Gagliano Nancy J | Purchase (P) | Common Stock | 2,100 | USD 2.37 | USD 4,977 | SEC filing ↗ |
| 2025-02-28 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 28,670 | USD 3.49 | USD 100,058 | SEC filing ↗ |
| 2025-02-27 | Gagliano Nancy J | Purchase (P) | Common Stock | 12,750 | USD 3.08 | USD 39,270 | SEC filing ↗ |
| 2025-02-27 | McGrath Kenneth J | Purchase (P) | Common Stock | 64,000 | USD 3.15 | USD 201,600 | SEC filing ↗ |
| 2025-02-27 | Marmora Lelio | Purchase (P) | Common Stock | 7,000 | USD 3.06 | USD 21,420 | SEC filing ↗ |
| 2025-02-27 | Kenny John P. | Purchase (P) | Common Stock | 47,659 | USD 3.17 | USD 151,079 | SEC filing ↗ |
| 2025-02-27 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 78,625 | USD 3.15 | USD 247,669 | SEC filing ↗ |
| 2023-05-30 | McGrath Kenneth J | Purchase (P) | Common Stock | 100,000 | USD 4.93 | USD 493,000 | SEC filing ↗ |
Form 4 evidence
37 transaction lines in the latest 365-day window; 315 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 4,797 | USD 3.88 | USD 18,612 | SEC filing ↗ |
| 2026-09-06 | Kenny John P. | Tax withholding (F) | Common Stock | 5,116 | USD 3.43 | USD 17,548 | SEC filing ↗ |
| 2026-06-26 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 3,666 | USD 4.43 | USD 16,240 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-29 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 4,797 | USD 3.88 | USD 18,612 | SEC filing ↗ |
| 2026-09-06 | Kenny John P. | Tax withholding (F) | Common Stock | 5,116 | USD 3.43 | USD 17,548 | SEC filing ↗ |
| 2026-06-26 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 3,666 | USD 4.43 | USD 16,240 | SEC filing ↗ |
| 2026-06-03 | McMahon Robert W. | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Marmora Lelio | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Kenny John P. | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Gagliano Nancy J | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-06-03 | Bertrand John D. | Award / grant (A) | Common Stock | 46,106 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 2.99 | USD 74,750 | SEC filing ↗ |
| 2026-05-13 | McMahon Robert W. | Tax withholding (F) | Common Stock | 22,888 | USD 3.02 | USD 69,122 | SEC filing ↗ |
| 2026-05-13 | Marmora Lelio | Tax withholding (F) | Common Stock | 28,406 | USD 3.02 | USD 85,786 | SEC filing ↗ |
| 2026-05-13 | Gagliano Nancy J | Tax withholding (F) | Common Stock | 21,305 | USD 3.02 | USD 64,341 | SEC filing ↗ |
| 2026-05-13 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 3.02 | USD 75,500 | SEC filing ↗ |
| 2026-05-12 | Boyd Steven Kyle | Purchase (P) | Common Stock | 25,000 | USD 2.98 | USD 74,500 | SEC filing ↗ |
| 2026-05-12 | Bertrand John D. | Award / grant (A) | Common Stock | 33,661 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-26 | Boyd Steven Kyle | Tax withholding (F) | Common Stock | 1,416 | USD 3.10 | USD 4,390 | SEC filing ↗ |
| 2026-03-26 | Boyd Steven Kyle | Award / grant (A) | Common Stock | 5,246 | USD 3.10 | USD 16,263 | SEC filing ↗ |
| 2026-03-20 | McGrath Kenneth J | Purchase (P) | Common Stock | 32,300 | USD 2.93 | USD 94,639 | SEC filing ↗ |
| 2026-03-20 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 32,300 | USD 2.93 | USD 94,639 | SEC filing ↗ |
| 2026-03-13 | McGrath Kenneth J | Purchase (P) | Common Stock | 22,021 | USD 3.00 | USD 66,063 | SEC filing ↗ |
| 2026-03-13 | EGLINTON MANNER CARRIE | Purchase (P) | Common Stock | 22,022 | USD 3.00 | USD 66,066 | SEC filing ↗ |
| 2026-03-02 | Anthony Michele Marie | Award / grant (A) | Common Stock | 42,982 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-02 | McGrath Kenneth J | Award / grant (A) | Common Stock | 88,348 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-02 | EGLINTON MANNER CARRIE | Award / grant (A) | Common Stock | 355,464 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-01 | Anthony Michele Marie | Tax withholding (F) | Common Stock | 14,879 | USD 3.04 | USD 45,232 | SEC filing ↗ |
| 2026-03-01 | Anthony Michele Marie | Award / grant (A) | Common Stock | 14,183 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-01 | McGrath Kenneth J | Tax withholding (F) | Common Stock | 28,384 | USD 3.04 | USD 86,287 | SEC filing ↗ |
| 2026-03-01 | McGrath Kenneth J | Award / grant (A) | Common Stock | 26,814 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-03-01 | EGLINTON MANNER CARRIE | Tax withholding (F) | Common Stock | 178,771 | USD 3.04 | USD 543,464 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | OSUR |
| CIK | 0001116463 |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies Yahoo Finance |
| SEC SIC | 3841 Surgical & Medical Instruments & Apparatus |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 315 transaction lines from 2020-02-01 to 2026-09-29 19 P purchase lines · 3 S sale lines · 293 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.